Modulation of Autophagy is a Potential Strategy for Enhancing the Anti-Tumor Effect of Mebendazole in Glioblastoma Cells |
Jo, Seong Bin
(Cancer Research Institute, College of Medicine, The Catholic University of Korea)
Sung, So Jung (Cancer Research Institute, College of Medicine, The Catholic University of Korea) Choi, Hong Seok (Cancer Research Institute, College of Medicine, The Catholic University of Korea) Park, Jae-Sung (Department of Neurosurgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea) Hong, Yong-Kil (Department of Neurosurgery, Hallym University Sacred Heart Hospital) Joe, Young Ae (Cancer Research Institute, College of Medicine, The Catholic University of Korea) |
1 | Sui, X., Chen, R., Wang, Z., Huang, Z., Kong, N., Zhang, M., Han, W., Lou, F., Yang, J., Zhang, Q., Wang, X., He, C. and Pan, H. (2013) Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment. Cell Death Dis. 4, e838. DOI |
2 | Takahashi, T., Yamaguchi, S., Chida, K. and Shibuya, M. (2001) A single autophosphorylation site on KDR/Flk-1 is essential for VEGFA-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells. EMBO J. 20, 2768-2778. DOI |
3 | Veliz, I., Loo, Y., Castillo, O., Karachaliou, N., Nigro, O. and Rosell, R. (2015) Advances and challenges in the molecular biology and treatment of glioblastoma-is there any hope for the future? Ann. Transl. Med. 3, 7. |
4 | Wang, Z., Gao, L., Guo, X., Feng, C., Lian, W., Deng, K. and Xing, B. (2019) Development and validation of a nomogram with an autophagy-related gene signature for predicting survival in patients with glioblastoma. Aging 11, 12246-12269. DOI |
5 | Stupp, R., Hegi, M. E., Mason, W. P., van den Bent, M. J., Taphoorn, M. J., Janzer, R. C., Ludwin, S. K., Allgeier, A., Fisher, B., Belanger, K., Hau, P., Brandes, A. A., Gijtenbeek, J., Marosi, C., Vecht, C. J., Mokhtari, K., Wesseling, P., Villa, S., Eisenhauer, E., Gorlia, T., Weller, M., Lacombe, D., Cairncross, J. G. and Mirimanoff, R. O.; European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups; National Cancer Institute of Canada Clinical Trials Group (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 10, 459-466. |
6 | Sung, S. J., Kim, H. K., Hong, Y. K. and Joe, Y. A. (2019) Autophagy is a potential target for enhancing the anti-angiogenic effect of mebendazole in endothelial cells. Biomol. Ther. (Seoul) 27, 117-125. DOI |
7 | Zhang, L., Guo, M., Li, J., Zheng, Y., Zhang, S., Xie, T. and Liu, B. (2015) Systems biology-based discovery of a potential Atg4B agonist (Flubendazole) that induces autophagy in breast cancer. Mol. Biosyst. 11, 2860-2866. DOI |
8 | Wu, W., Klockow, J. L., Zhang, M., Lafortune, F., Chang, E., Jin, L., Wu, Y. and Daldrup-Link, H. E. (2021) Glioblastoma multiforme (GBM): an overview of current therapies and mechanisms of resistance. Pharmacol. Res. 171, 105780. DOI |
9 | Yun, C. W. and Lee, S. H. (2018) The roles of autophagy in cancer. Int. J. Mol. Sci. 19, 3466. DOI |
10 | Zhang, H., Lu, X., Wang, N., Wang, J., Cao, Y., Wang, T., Zhou, X., Jiao, Y., Yang, L., Wang, X., Cong, L., Li, J., Li, J., Ma, H. P., Pan, Y., Ning, S. and Wang, L. (2017) Autophagy-related gene expression is an independent prognostic indicator of glioma. Oncotarget 8, 60987-61000. DOI |
11 | Briceno, E., Calderon, A. and Sotelo, J. (2007) Institutional experience with chloroquine as an adjuvant to the therapy for glioblastoma multiforme. Surg. Neurol. 67, 388-391. DOI |
12 | Wang, Y., Zhao, W., Xiao, Z., Guan, G., Liu, X. and Zhuang, M. (2020) A risk signature with four autophagy-related genes for predicting survival of glioblastoma multiforme. J. Cell. Mol. Med. 24, 3807-3821. DOI |
13 | Xiao, M., Benoit, A., Hasmim, M., Duhem, C., Vogin, G., Berchem, G., Noman, M. Z. and Janji, B. (2021) Targeting cytoprotective autophagy to enhance anticancer therapies. Front. Oncol. 11, 626309. DOI |
14 | Zhang, J., Stevens, M. F. and Bradshaw, T. D. (2012) Temozolomide: mechanisms of action, repair and resistance. Curr. Mol. Pharmacol. 5, 102-114. DOI |
15 | Bai, R. Y., Staedtke, V., Wanjiku, T., Rudek, M. A., Joshi, A., Gallia, G. L. and Riggins, G. J. (2015b) Brain penetration and efficacy of different mebendazole polymorphs in a mouse brain tumor model. Clin. Cancer Res. 21, 3462-3470. DOI |
16 | Bai, R. Y., Staedtke, V., Aprhys, C. M., Gallia, G. L. and Riggins, G. J. (2011) Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme. Neuro Oncol. 13, 974-982. DOI |
17 | Bai, R. Y., Staedtke, V., Rudin, C. M., Bunz, F. and Riggins, G. J. (2015a) Effective treatment of diverse medulloblastoma models with mebendazole and its impact on tumor angiogenesis. Neuro Oncol. 17, 545-554. DOI |
18 | Boyle, F. M., Eller, S. L. and Grossman, S. A. (2004) Penetration of intra-arterially administered vincristine in experimental brain tumor. Neuro Oncol. 6, 300-305. DOI |
19 | Choi, A. M. K., Ryter, S. W. and Levine, B. (2013a) Autophagy in human health and disease. N. Engl. J. Med. 368, 651-662. DOI |
20 | Chang, H. and Zou, Z. (2020) Targeting autophagy to overcome drug resistance: further developments. J. Hematol. Oncol. 13, 159. DOI |
21 | Choi, M., Lee, H. S., Naidansaren, P., Kim, H. K., O, E., Cha, J. H., Ahn, H. Y., Yang, P. I., Shin, J. C. and Joe, Y. A. (2013b) Proangiogenic features of Wharton's jelly-derived mesenchymal stromal/ stem cells and their ability to form functional vessels. Int. J. Biochem. Cell Biol. 45, 560-570. DOI |
22 | De Witt, M., Gamble, A., Hanson, D., Markowitz, D., Powell, C., Al Dimassi, S., Atlas, M., Boockvar, J., Ruggieri, R. and Symons, M. (2017) Repurposing mebendazole as a replacement for vincristine for the treatment of brain tumors. Mol. Med. 23, 50-56. |
23 | Doudican, N., Rodriguez, A., Osman, I. and Orlow, S. J. (2008) Mebendazole induces apoptosis via Bcl-2 inactivation in chemoresistant melanoma cells. Mol. Cancer Res. 6, 1308-1315. DOI |
24 | Mukhopadhyay, T., Sasaki, J., Ramesh, R. and Roth, J. A. (2002) Mebendazole elicits a potent antitumor effect on human cancer cell lines both in vitro and in vivo. Clin. Cancer Res. 8, 2963-2969. |
25 | Golden, E. B., Cho, H. Y., Jahanian, A., Hofman, F. M., Louie, S. G., Schonthal, A. H. and Chen, T. C. (2014) Chloroquine enhances temozolomide cytotoxicity in malignant gliomas by blocking autophagy. Neurosurg. Focus 37, E12. |
26 | Hori, Y. S., Hosoda, R., Akiyama, Y., Sebori, R., Wanibuchi, M., Mikami, T., Sugino, T., Suzuki, K., Maruyama, M., Tsukamoto, M., Mikuni, N., Horio, Y. and Kuno, A. (2015) Chloroquine potentiates temozolomide cytotoxicity by inhibiting mitochondrial autophagy in glioma cells. J. Neurooncol. 122, 11-20. DOI |
27 | Kanzawa, T., Germano, I. M., Komata, T., Ito, H., Kondo, Y. and Kondo, S. (2004) Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. Cell Death Differ. 11, 448-457. DOI |
28 | Kaur, R., Kaur, G., Gill, R. K., Soni, R. and Bariwal, J. (2014) Recent developments in tubulin polymerization inhibitors: an overview. Eur. J. Med. Chem. 87, 89-124. DOI |
29 | Lacey, E. (1988) The role of the cytoskeletal protein, tubulin, in the mode of action and mechanism of drug resistance to benzimidazoles. Int. J. Parasitol. 18, 885-936. DOI |
30 | Laclette, J. P., Guerra, G. and Zetina, C. (1980) Inhibition of tubulin polymerization by Mebendazole. Biochem. Biophys. Res. Commun. 92, 417-423. DOI |
31 | Munst, G. J., Karlaganis, G. and Bircher, J. (1980) Plasma concentrations of mebendazole during treatment of echinococcosis: preliminary results. Eur. J. Clin. Pharmacol. 17, 375-378. DOI |
32 | Jung, Y. Y., Baek, S. H., Ha, I. J. and Ahn, K. S. (2022) Regulation of apoptosis and autophagy by albendazole in human colon adenocarcinoma cells. Biochimie 198, 155-166. DOI |
33 | Bellodi, C., Lidonnici, M. R., Hamilton, A., Helgason, G. V., Soliera, A. R., Ronchetti, M., Galavotti, S., Young, K. W., Selmi, T., Yacobi, R., Van Etten, R. A., Donato, N., Hunter, A., Dinsdale, D., Tirro, E., Vigneri, P., Nicotera, P., Dyer, M. J., Holyoake, T., Salomoni, P. and Calabretta, B. (2009) Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosomepositive cells, including primary CML stem cells. J. Clin. Invest. 119, 1109-1123. DOI |
34 | Compter, I., Eekers, D. B. P., Hoeben, A., Rouschop, K. M. A., Reymen, B., Ackermans, L., Beckervordersantforth, J., Bauer, N. J. C., Anten, M. M., Wesseling, P., Postma, A. A., De Ruysscher, D. and Lambin, P. (2021) Chloroquine combined with concurrent radiotherapy and temozolomide for newly diagnosed glioblastoma: a phase IB trial. Autophagy 17, 2604-2612. DOI |
35 | Friedman, P. A. and Platzer, E. G. (1980) Interaction of anthelmintic benzimidazoles with Ascaris suum embryonic tubulin. Biochim. Biophys. Acta, Gen. Subj. 630, 271-278. DOI |
36 | Singh, N., Miner, A., Hennis, L. and Mittal, S. (2021) Mechanisms of temozolomide resistance in glioblastoma - a comprehensive review. Cancer Drug Resist. 4, 17-43. |
37 | Pantziarka, P., Bouche, G., Meheus, L., Sukhatme, V. and Sukhatme, V. P. (2014) Repurposing Drugs in Oncology (ReDO)-mebendazole as an anti-cancer agent. Ecancermedicalscience 8, 443. |
38 | Pinto, L. C., Soares, B. M., Pinheiro Jde, J., Riggins, G. J., Assumpcao, P. P., Burbano, R. M. and Montenegro, R. C. (2015) The anthelmintic drug mebendazole inhibits growth, migration and invasion in gastric cancer cell model. Toxicol. In Vitro 29, 2038-2044. DOI |
39 | Shin, D. W. (2020) Dual roles of autophagy and their potential drugs for improving cancer therapeutics. Biomol. Ther. (Seoul) 28, 503-511. DOI |
40 | Kim, H. K., Oh, D. S., Lee, S. B., Ha, J. M. and Joe, Y. A. (2008) Antimigratory effect of TK1-2 is mediated in part by interfering with integrin alpha2beta1. Mol. Cancer Ther. 7, 2133-2141. DOI |
41 | Lee, S. W., Kim, H. K., Lee, N. H., Yi, H. Y., Kim, H. S., Hong, S. H., Hong, Y. K. and Joe, Y. A. (2015) The synergistic effect of combination temozolomide and chloroquine treatment is dependent on autophagy formation and p53 status in glioma cells. Cancer Lett. 360, 195-204. DOI |
42 | Poole, B. and Ohkuma, S. (1981) Effect of weak bases on the intralysosomal pH in mouse peritoneal macrophages. J. Cell Biol. 90, 665-669. DOI |
43 | Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., Curschmann, J., Janzer, R. C., Ludwin, S. K., Gorlia, T., Allgeier, A., Lacombe, D., Cairncross, J. G., Eisenhauer, E. and Mirimanoff, R. O.; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 352, 987-996. DOI |
44 | Paglin, S., Hollister, T., Delohery, T., Hackett, N., McMahill, M., Sphicas, E., Domingo, D. and Yahalom, J. (2001) A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles. Cancer Res. 61, 439-444. |